Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
At Navitas Life Sciences, we pride ourselves on being at the forefront of providing comprehensive medical and regulatory consulting services that help our clients achieve operational excellence, ensure compliance, and act as a catalyst for increased competitiveness, efficiency and speed to market. As one of the top medical and regulatory consulting...
In the intricate world of pharmaceutical development, where the stakes are high, deadlines are tight, and precision is non-negotiable, the role of medical writing has never been more crucial. Against this backdrop, our recent Medical Writing Roundtable, co-led by Novo-Nordisk, brought together industry leaders from nine global companies, from EU, U...
Designing complex innovative protocols for Oncology clinical trials is a complex process that must balance scientific rigor, regulatory requirements, and patient-centric care. This process has become increasingly critical as advancements in genomics, immunotherapy, and other novel therapeutic strategies are reshaping cancer treatments. By integrati...
Driving transformation in the drug development landscape requires more than just adapting to changes; it demands leading them. At Navitas Life Sciences, we don't just overcome complexities of clinical trials—we shape them, setting new standards for efficiency, precision, and compliance. By integrating cutting-edge technology and a deep under...
As we mark Immunization Awareness Month 2024, it's imperative to spotlight the critical role of vaccines in public health and the intricate processes behind their development. At Navitas Life Sciences, our commitment to combating infectious diseases through rigorous clinical trials underscores our dedication to advancing global health. With over 30...
The recent announcement by the US Food and Drug Administration (FDA) regarding laboratory-developed tests (LDTs) indicates that increased enforcement of established medical device regulations will now apply to all in vitro diagnostic (IVD) products, including LDTs. The FDA LDT announcement, referring to the previous FDA LDT ruling, marks the end of...
The recent shift in the UK's regulatory landscape, marked by the adoption of the International Recognition Procedure (IRP) by the Medicines and Healthcare products Regulatory Agency (MHRA), is a significant milestone for the pharmaceutical industry. This new procedure, which replaced the European Commission Decision Reliance Procedure (ECDRP) as of...
At Navitas Life Sciences, we are at the forefront of providing comprehensive regulatory services that ensure compliance, accelerate time-to-market, and enhance patient outcomes. Our commitment to innovation, precision, and excellence helps us shape personalised solutions to support across the entire product lifecycle. Navitas Life Sciences understa...
How Navitas Life Sciences grew to be a Strategic Partner for Top Pharma across the World Clinical trials are the backbone of modern medical advancements, driving the development of new treatments and therapies that improve patient lives. For the past three decades, Navitas Life Sciences has been at the forefront of supporting and transforming the c...
The global clinical trials market, valued at USD 80.7 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 6.49% from 2024 to 2030. This expansion highlights the critical importance of selecting the right Contract Research Organization (CRO) to manage efficient and compliant clinical trials. In our latest blog, we discus...